Cover Image

Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α

Objective: To clarify the potential therapeutic effects of thymoquinone (TQ) on pancreatic cancer and its gemcitabine (GEM) sensitivity.Methods: The expression levels of hypoxia inducible factor-1α (HIF-1α), collagens (COL1A1, COL3A1, and COL5A1), and transforming growth factor-β1 (TGFβ1) in pancrea...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhanxue Zhao (Author), Linxun Liu (Author), Hekai Chen (Author), Shuai Li (Author), Yan Guo (Author), Xiaofan Hou (Author), Jinyu Yang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway
by: Tianli Zhang, et al.
Published: (2022)

High-intensity focused ultrasound therapy in combination with gemcitabine for unresectable pancreatic carcinoma
by: Lv W, et al.
Published: (2016)

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer
by: Zelin Hou, et al.
Published: (2023)

PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell
by: Hualian Zha, et al.
Published: (2022)

M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
by: Yongmei Zhao, et al.
Published: (2021)

Gemcitabine Combination Nano Therapies for Pancreatic Cancer
by: Kamalika Samanta, et al.
Published: (2019)

c-Myc-PD-L1 Axis Sustained Gemcitabine-Resistance in Pancreatic Cancer
by: Jingjing Yao, et al.
Published: (2022)

Downregulation of Hypoxia-Inducible Factor-1α by RNA Interference Alleviates the Development of Collagen-Induced Arthritis in Rats
by: Yiping Hu, et al.
Published: (2020)

Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells
by: Xu Zhu, et al.
Published: (2018)

Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells
by: Tormod Bjånes, et al.
Published: (2020)

Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors
by: Kentaro Minami, et al.
Published: (2015)

Cardamonin Promotes the Apoptosis and Chemotherapy Sensitivity to Gemcitabine of Pancreatic Cancer Through Modulating the FOXO3a-FOXM1 Axis
by: Huapeng Sun, et al.
Published: (2021)

Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy
by: Christian Marin-Muller, et al.
Published: (2023)

Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy
by: Miguel Pereira-Silva, et al.
Published: (2024)

Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
by: Feng Shao, et al.
Published: (2018)

Dabigatran Potentiates Gemcitabine-Induced Growth Inhibition of Pancreatic Cancer in Mice
by: Kun Shi, et al.
Published: (2017)

Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models
by: Andriana Inkoom, et al.
Published: (2020)

Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells
by: Immacolata Maietta, et al.
Published: (2022)

Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer
by: Ji Min Park, et al.
Published: (2022)

Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis
by: Wang Y, et al.
Published: (2016)

Expression of hypoxia inducible factor-1α and vascular endothelial growth factor-C in human chronic periodontitis
by: Qing-Yan Shi, et al.
Published: (2015)

Pharmacodynamic Modeling of Cell Cycle Effects for Gemcitabine and Trabectedin Combinations in Pancreatic Cancer Cells
by: Xin Miao, et al.
Published: (2016)

KHSRP knockdown inhibits papillary renal cell carcinoma progression and sensitizes to gemcitabine
by: Wei Song, et al.
Published: (2024)

Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling
by: Jing Cui, et al.
Published: (2021)

Mechanistic Multiscale Pharmacokinetic Model for the Anticancer Drug 2',2'‐difluorodeoxycytidine (Gemcitabine) in Pancreatic Cancer
by: Maria Garcia‐Cremades, et al.
Published: (2020)

Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction
by: Da Eun Lee, et al.
Published: (2022)

LncRNA TUG1 promoted viability and associated with gemcitabine resistant in pancreatic ductal adenocarcinoma
by: Fan Yang, et al.
Published: (2018)

Preparation of Cod Skin Collagen Peptides/Chitosan-Based Temperature-Sensitive Gel and Its Anti-Photoaging Effect in Skin
by: Kong S, et al.
Published: (2023)

Targeting Hypoxia-Inducible Factor-1α in Pancreatic Cancer: siRNA Delivery Using Hyaluronic Acid-Displaying Nanoparticles
by: Alice Spadea, et al.
Published: (2024)

SLC39A1 contributes to gemcitabine resistance of pancreatic ductal adenocarcinoma by activating AMPK signaling
by: Hao Yu, et al.
Published: (2024)

Tissue distribution of crizotinib and gemcitabine combination in a patient-derived orthotopic mouse model of pancreatic cancer
by: Richard J. Honeywell, et al.
Published: (2016)

Sparstolonin B Exerts Therapeutic Effects on Collagen-Induced Arthritis by Inhibiting the NLRP3 Inflammasome and Reducing the Activity of α1,3-Fucosyltransferase
by: Yue Sun, et al.
Published: (2021)

T-Cell Exhaustion Status Under High and Low Levels of Hypoxia-Inducible Factor 1α Expression in Glioma
by: Shuai Liu, et al.
Published: (2021)

Targeting the hypoxia pathway to treat pancreatic cancer
by: Erickson LA, et al.
Published: (2015)

Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models
by: Emilia Rabia, et al.
Published: (2021)

In vivo real-time imaging of gemcitabine-leaded growth inhibition in the orthotopic transplantation model of human pancreatic tumor
by: Sheng-hua Zhang, et al.
Published: (2011)

An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma
by: Zhijun Xiao, et al.
Published: (2021)

Multi‐Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer Cells
by: Xu Zhu, et al.
Published: (2018)

The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma
by: Ling-Wei Hii, et al.
Published: (2019)

Hypoxia Inducible Factor1α in Correlation with Preeclampsia
by: Hendrik Juarsa, et al.
Published: (2016)